ARTICLE | Company News
ID Biomedical option deal with DiscoveRx
July 20, 2000 7:00 AM UTC
IDBE granted DiscoveRx (Fremont, Calif.) an 18-month option to obtain a worldwide non-exclusive license to IDBE's Cycling Probe Technology genomic detection platform for use with DiscoveRx's enzyme fr...